Metabolic biomarker profiling for identification of susceptibility to severe pneumonia and COVID-19 in the general population

  1. Nightingale Health UK Biobank Initiative
  2. Heli Julkunen
  3. Anna Cichońska
  4. P Eline Slagboom
  5. Peter Würtz  Is a corresponding author
  1. Nightingale Health Ltd, Finland
  2. Leiden University Medical Center, Netherlands

Peer review process

This article was accepted for publication via eLife's original publishing model. eLife publishes the authors' accepted manuscript as a PDF only version before the full Version of Record is ready for publication. Peer reviews are published along with the Version of Record.

History

  1. Version of Record published
  2. Accepted Manuscript published
  3. Accepted
  4. Received

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Nightingale Health UK Biobank Initiative
  2. Heli Julkunen
  3. Anna Cichońska
  4. P Eline Slagboom
  5. Peter Würtz
(2021)
Metabolic biomarker profiling for identification of susceptibility to severe pneumonia and COVID-19 in the general population
eLife 10:e63033.
https://doi.org/10.7554/eLife.63033

Share this article

https://doi.org/10.7554/eLife.63033